Hyaluronan based heparin free coated open and closed extracorporeal circuits for high risk coronary revascularization.

This prospective randomized study compares the inflammatory response and fibrinolytic activation of fully coated/uncoated and open/closed extracorporeal circuits (ECC) in high risk patients. Over a 2-month period, 48 patients with EuroSCOREs 6 or greater undergoing coronary revascularization were prospectively randomized to one of the four perfusion protocols: Group 1: Closed and totally hyaluronan based heparin free coated (Vision HFO-GBS-HF, Gish Biomedical, Rancho Santa Margarita, CA) ECC with a soft-shell coated venous reservoir (SVR11S2-HFC, Gish Biomedical) and a hard-shell cardiotomy (CAPVRF44, Gish Biomedical) (n = 12); Group 2: Closed and totally uncoated identical ECC with soft-shell uncoated venous reservoir and a hard-shell cardiotomy (n = 12); Group 3: Open, totally hyaluronan based heparin free coated ECC (n = 12); and Group 4: Control-open, uncoated ECC (n = 12). Blood samples were collected at T1: Baseline; T2: 15 minutes after cardiopulmonary bypass (CPB) initiation; T3: before cessation of CPB; T4: 15 minutes after protamine reversal, and T5: in the intensive care unit. Serum IL-6 levels were significantly lower at T2 in all study groups, at T3 for coated groups, and T4 for closed+coated group (p < .05 versus control). Creatine kinase M-band (MB) levels in coronary sinus blood demonstrated well preserved myocardium after CPB in both coated groups versus Control (p < .05). Neutrophil CD11b/CD18 levels were significantly lower for all study groups versus control at T2, for both coated groups at T3 and only for closed + coated group at T4 (p < .05). Postoperative hemorrhage (mL) was 510 +/- 40 in closed + coated and 536 +/- 40 in open + coated groups (control: 784 +/- 48, p < .05). No significant differences in thrombin-antithrombin complex and free plasma hemoglobin were observed. Desorbed protein amount on ECC (mg/dL) was 1.7 +/- .01 in closed+coated, 2.01 +/- .01 in open+coated, and 3.3 +/- .015 in control groups (p < or = .05). Use of a closed and completely heparin free coated ECC may reduce neutrophil degradation, cytokine release characterized by improved clinical outcomes including reduced blood loss, reduced requirement for inotropes, and reduced atrial fibrillation.

[1]  T. Fukui,et al.  Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting. , 2010, Interactive cardiovascular and thoracic surgery.

[2]  Y. Zorlutuna,et al.  Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts. , 2010, Interactive cardiovascular and thoracic surgery.

[3]  K. Mccusker,et al.  Clinical and Biomaterial Evaluation of a new Condensed Dual-Function Extracorporeal Circuit in Reoperation for Coronary Artery Bypass Surgery , 2009 .

[4]  Y. Zorlutuna,et al.  Clinical evaluation of minimized extracorporeal circulation in high-risk coronary revascularization: impact on air handling, inflammation, hemodilution and myocardial function , 2009, Perfusion.

[5]  Y. Zorlutuna,et al.  Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization , 2009, Journal of cardiovascular medicine.

[6]  M. Diena,et al.  Reduced transfusion requirements with a closed cardiopulmonary bypass system. , 2008, The Journal of cardiovascular surgery.

[7]  M. Cámara,et al.  Cirugía coronaria con mini-circulación extracorpórea: experiencia de un grupo en España , 2008 .

[8]  V. Vijay,et al.  Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits. , 2005, The journal of extra-corporeal technology.

[9]  R. Groom.  A Systematic Approach to the Understanding and Redesigning of Cardiopulmonary Bypass , 2005, Seminars in cardiothoracic and vascular anesthesia.

[10]  J. Sistino,et al.  The effectiveness of low-prime cardiopulmonary bypass circuits at removing gaseous emboli. , 2004, The journal of extra-corporeal technology.

[11]  G. Rizzi,et al.  Biomedical Coatings to Improve the Tissue-Biomaterial Interface , 2004 .

[12]  L. V. von Segesser,et al.  Miniaturization in cardiopulmonary bypass , 2003, Perfusion.

[13]  G. Tangen,et al.  Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations. , 2001, The Journal of thoracic and cardiovascular surgery.

[14]  A. Mochizuki,et al.  Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA)--relationship between protein adsorption and platelet adhesion on PMEA surface. , 2000, Biomaterials.

[15]  R. Salamon,et al.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  Y. Tomizawa,et al.  Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass. , 1999, Artificial organs.

[17]  E. Fosse,et al.  Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population. , 1999, The Journal of thoracic and cardiovascular surgery.

[18]  E. Fosse,et al.  Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. , 1996, The Annals of thoracic surgery.

[19]  H. Repo,et al.  Flow cytometric determination of CD11b upregulation in vivo. , 1993, Journal of immunological methods.

[20]  V. Vijay,et al.  Clinical and biomaterial evaluation of a new condensed dual-function extracorporeal circuit in reoperation for coronary artery bypass surgery. , 2009, The International journal of artificial organs.

[21]  E. Zamora,et al.  [Coronary artery bypass surgery using the mini-extracorporeal circulation system: a Spanish unit's experience]. , 2008, Revista espanola de cardiologia.

[22]  G. Rizzi,et al.  Biomedical coatings to improve the tissue-biomaterial interface. , 2004, The International journal of artificial organs.

[23]  T. Abe,et al.  Comparative Study of the Effect on Clinical Outcome of the Use of an Open Circuit and the Use of a Closed Circuit in Cardiopulmonary Bypass for a Graft Replacement of the Descending Thoracic or Thoracoabdominal Aorta , 2003, Surgery Today.